Gruen A, Tegel K, Kluge A, Budach V, et al. PSMA PET-based stereotactic body radiotherapy for locally recurrent prostate cancer after definitive first-line therapy. Prostate 2023 Jul 2. doi: 10.1002/pros.24592.
PMID: 37394721